Milk levels of amitriptyline and its metabolites are low. Immediate side effects have not been reported and a limited amount of follow-up has found no adverse effects on infant growth and development. Amitriptyline use during breastfeeding would usually not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. A safety scoring system finds amitriptyline use to be possible with caution during breastfeeding.[1] However, rare sedation has been reported in a neonate. Other agents with fewer active metabolites may be preferred when large doses are required or while nursing a newborn or preterm infant.
阿米替林及其代谢产物在乳汁中的含量较低。尚未有关于即刻副作用的报道,且有限的随访发现对婴儿生长发育无不良影响。母乳喂养期间使用阿米替林通常预计不会对母乳喂养的婴儿造成任何不良影响,尤其是婴儿年龄大于2个月时。一种安全评分系统认为母乳喂养期间谨慎使用阿米替林是可行的。[1]然而,有报道称一名新生儿出现罕见的镇静作用。当需要大剂量用药或喂养新生儿或早产儿期间,可能更倾向于选用活性代谢产物较少的其他药物。